HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working, but they’re costly and cumbersome. Meanwhile, African biostatisticians have offered a powerful, data-driven alternative that can accurately inform HIV policy, reduce health care costs, and save more lives.
This article was originally published on MedicalXpress.com

